Alfa-epoietin and Anaemia in Gynaecological Cancer

Barbara Di Cocco; Nello Salesi; Alessandra Fabi; Chiara Nardoni; Gianluigi Ferretti; Giandominik Bossone; Mariangela Ciccarese; Antonella Savarese; Aldo Vecchione; Francesco Cognetti

Alfa-epoietin and Anaemia in Gynaecological Cancer

Barbara Di Cocco, Nello Salesi, Alessandra Fabi, Chiara Nardoni, Gianluigi Ferretti, Giandominik Bossone, Mariangela Ciccarese, Antonella Savarese, Aldo Vecchione, Francesco Cognetti

Istituto Regina Elena

Research output: Contribution to journal › Article › peer-review

Abstract

The incidence and severity of anaemia in gynaecological cancer patients depends on several factors including age, histology and tumor stage, site of neoplasm and treatment. At present, two principal opinions are available for the management of chronic anaemia in cancer patients: blood transfusions and treatment with recombinant human Erythropoietin (rHuEPO). Clinical studies showed that rHuEPO can ameliorate chronic and chemotherapy-induced anaemia and reduce transfusions in patients with various malignant diseases. In this review we discuss the role of alfa-epoetin in the management of gynaecological and breast cancers.

Original language	English
Pages (from-to)	1287-1292
Number of pages	6
Journal	Anticancer Research
Volume	24
Issue number	2 C
Publication status	Published - Mar 2004

Keywords

Alfa-erythropoietin
Anaemia
Gynaecological cancer

ASJC Scopus subject areas

Cancer Research
Oncology

Cite this

@article{4ceab7b1fc0346dda1185892a4c9b845,

title = "Alfa-epoietin and Anaemia in Gynaecological Cancer",

abstract = "The incidence and severity of anaemia in gynaecological cancer patients depends on several factors including age, histology and tumor stage, site of neoplasm and treatment. At present, two principal opinions are available for the management of chronic anaemia in cancer patients: blood transfusions and treatment with recombinant human Erythropoietin (rHuEPO). Clinical studies showed that rHuEPO can ameliorate chronic and chemotherapy-induced anaemia and reduce transfusions in patients with various malignant diseases. In this review we discuss the role of alfa-epoetin in the management of gynaecological and breast cancers.",

keywords = "Alfa-erythropoietin, Anaemia, Gynaecological cancer",

author = "{Di Cocco}, Barbara and Nello Salesi and Alessandra Fabi and Chiara Nardoni and Gianluigi Ferretti and Giandominik Bossone and Mariangela Ciccarese and Antonella Savarese and Aldo Vecchione and Francesco Cognetti",

year = "2004",

month = mar,

language = "English",

volume = "24",

pages = "1287--1292",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "2 C",

}

TY - JOUR

T1 - Alfa-epoietin and Anaemia in Gynaecological Cancer

AU - Di Cocco, Barbara

AU - Salesi, Nello

AU - Fabi, Alessandra

AU - Nardoni, Chiara

AU - Ferretti, Gianluigi

AU - Bossone, Giandominik

AU - Ciccarese, Mariangela

AU - Savarese, Antonella

AU - Vecchione, Aldo

AU - Cognetti, Francesco

PY - 2004/3

Y1 - 2004/3

N2 - The incidence and severity of anaemia in gynaecological cancer patients depends on several factors including age, histology and tumor stage, site of neoplasm and treatment. At present, two principal opinions are available for the management of chronic anaemia in cancer patients: blood transfusions and treatment with recombinant human Erythropoietin (rHuEPO). Clinical studies showed that rHuEPO can ameliorate chronic and chemotherapy-induced anaemia and reduce transfusions in patients with various malignant diseases. In this review we discuss the role of alfa-epoetin in the management of gynaecological and breast cancers.

AB - The incidence and severity of anaemia in gynaecological cancer patients depends on several factors including age, histology and tumor stage, site of neoplasm and treatment. At present, two principal opinions are available for the management of chronic anaemia in cancer patients: blood transfusions and treatment with recombinant human Erythropoietin (rHuEPO). Clinical studies showed that rHuEPO can ameliorate chronic and chemotherapy-induced anaemia and reduce transfusions in patients with various malignant diseases. In this review we discuss the role of alfa-epoetin in the management of gynaecological and breast cancers.

KW - Alfa-erythropoietin

KW - Anaemia

KW - Gynaecological cancer

UR - http://www.scopus.com/inward/record.url?scp=2442497454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442497454&partnerID=8YFLogxK

M3 - Article

C2 - 15154662

AN - SCOPUS:2442497454

SN - 0250-7005

VL - 24

SP - 1287

EP - 1292

JO - Anticancer Research

JF - Anticancer Research

IS - 2 C

ER -

Alfa-epoietin and Anaemia in Gynaecological Cancer

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this